Effect of candesartan cilexetil with hydrochlorothiazide on blood pressure and ST-segment depression in patients with arterial hypertension;Blutdruck- und ST-streckenanalyse bei patienten mit arterieller hypertonie: Einfluss von candesartan/hydrochlorothiazid

Deutsche Medizinische Wochenschrift

Volumn 132, Issue 3, 2007, Pages 81-86

  Uen, Sakir ^a,c   Un, I ^b   Fimmers, R ^a   Vetter, H ^a   Mengden, T ^a  

^a UNIVERSITY OF BONN   (Germany)

^b MERSIN UNIVERSITY   (Turkey)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Combined 24 h ABPM ECG; Silent myocardial ischemia; Uncontrolled arterial hypertension

Indexed keywords

CANDESARTAN HEXETIL; HYDROCHLOROTHIAZIDE; ANTIHYPERTENSIVE AGENT; BENZIMIDAZOLE DERIVATIVE; BIPHENYL DERIVATIVE; TETRAZOLE DERIVATIVE;

ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DRUG EFFECT; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; ST SEGMENT DEPRESSION; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; AGED; BLOOD PRESSURE; DRUG COMBINATION; METHODOLOGY; MIDDLE AGED;

AGED; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BIPHENYL COMPOUNDS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MIDDLE AGED; TETRAZOLES; TREATMENT OUTCOME;

EID: 33847328773     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-959292     Document Type: Article

References (25)

1. Aronow WS, Ahn C, Mercando AD, Epstein S, Kronzon I. Prevalence of and association between silent myocardial ischemia and coronary events in older men and women with and without cardiovascular disease. J Am Geriatr Soc 2002; 50: 1075-1082
2. Barna I, Keszei A, Dunai A. Evaluation of Meditech ABPM 04 ambulatory BP measuring devices according to the British Hypertension Society protocol. Blood Press Monit 1998; 3: 363-368
3. Bertolet BD, Hill JA, Pepine CJ. Treatment stratgies for daily life silent myocardial ischemia: a correlation with potential pathogenic mechanism. Prog Cardiovasc Dis 1992; 35: 97-118
4. Boon D, Piek JJ, van Montfrans GA. Silent ischemia and hypertension. J Hypertens 2000; 18: 1355-1364
5. Dahlhöf B, Devereux RB, Kjeldsen SE et al. Cardiovascular morbidity and mortality in the losartan intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359: 995-1003
6. Davis RF, Goldberg AD, Forman S et al. Aysmtomatic Cardiac Ischemia Pilot (ACIP) Study Two-Year follow-up. Circulation 1997; 95: 2037-2043
7. Deewania PC, Carbajan EV. Silent ischemia during daily life an independent risk predictor of mortality in stable angina. Circulation 1990; 81: 748-756
8. Deedwania PC, Carbajal EV, Nelson JR et al. Antiischemic effect of atenolol versus nifedipine in patients with with coronary artery disease and ambulatory silent myocardial ischemia. J Am Coll Cardiol 1991; 17: 963-969
9. Hagert D, Teichmann W. Myocardial ischemia in hypertensives. Med Klin 2001; 96: 256-260
10. Jalowy A, Schulz R, Heusch G. AT1 receptor blockade in experimental myocardial ischemia/reperfusion. J Am Soc Nephrol 1999; 10 (Suppl 11): 129-136
11. Klingbeil AU, Schneider M, Martus P, Messerti FH. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med 2003; 115: 41-46
12. Nalbantgil I, Önder S, Yilmaz H, Boydak B. The prevalence of silent myocardial ischemia in patients with white-coat hypertension. J Hum Hypertens 1998; 12: 337-341
13. Pepine CJ, Sharaf B, Andrew TC et al. Relation between clinical, angiographic and ischemic findings at baseline and ischemia related adverse outcames at 1 year in the Asymptomatic Cardiac Ischemia Pilot study. ACIP Study Group. J Am coll Cardiol 1997; 29: 1483-1489
14. Pepine CJ, Cohn PF, Deedwania PC et al. The prognostic and economic implications of a strategy to detect and treat asymtomatic ischemia: the Atenolol Silent Ischemia Trial (ASIST) protocol. Clin Cardiol 1991; 14: 457-462
15. Pepine CJ. B-Blockers or calcium antagonists in silent ischemia? European Hear Journal 1993; 14 (Supplement): 7-14
16. Raby KE, Barry J, Treasure CB et al.. Usefulness of Holter monitoring for detecting myocardial ischemia in patients with nondiagnostic exercise treadmill test. Am J Cardiol 1993; 72: 889-893
17. Rogoza AN, Pavlova TS, Sergeeva MV. Validation of the A&D UA-767 device for the self-measurement of blood pressure. Blood Press Monit 2000; 5: 227-231
18. Schillad G, Pirro M, Pasqualini L et al. Prognostic significance of isolated non-specific left ventricular repolarization abnormalities in hypertensive. J Hypertens 2004; 22: 407-414
19. Sigurdson E, Sigfusson N, Sigvaldson H, Thorgeirsson G. Silent ST-T changes in an epidemiologic chort study - A marker of hypertension or coronary heart disease, or both: The Reykjavik study. J Am coll Cardiol 1996; 27: 1140-1147
20. Singh N, Mironov D, Goodmann S, Morgan CD, Langer A. Treatment of silent ischemia in unstable angina: a randomized comparison of sustained-release verapamil versus metoprolol. Clin Cardiol 1995; 18: 653-658
21. Stone PH, Chaitman BR, McMahon RP et al. Aysmtomatic Cardiac Ischemia Pilot (ACIP) Study. Circulation 1996; 94: 1537-1544
22. Thomas JP, Moya JL, Barrios V et al. Effect of candesartan on coronary flow reserve in patients with systemic hypertension. J Hypertens 2006; 24: 2109-2114
23. Trenkwalder P, Dobrint R, Aulehner R, Lydtin H. Antihypertensive treatment with felodipine but not with a diuretic reduces episodes of myocardial ischemia in elderly patients with hypertension. Eur Heart J 1994; 15: 1673-1680
24. Uen S, Baulmann J, Düsing R, Glänzer K, Vetter H, Mengden T. ST- segment depression in hypertensive patients is linked to elevation in blood pressure, pulse pressure and double product by 24-h Cardiotens monitoring. J Hypertens 2003; 21: 977-983
25. Uen S, Un I, Fimmers R, Vetter H, Mengden T. Myocardial ischemia during everyday life in patients with arterial hypertension: prevalence, risk factors, triggering mechanism and circadian variability. Blood Press Monit 2006; 11: 173-182